Bristol-Myers Squibb Company Statistics

Total Valuation

Bristol-Myers Squibb Company has a market cap or net worth of GBP 96.19 billion. The enterprise value is 130.84 billion.

Market Cap	96.19B
Enterprise Value	130.84B

Important Dates

The next estimated earnings date is Thursday, February 6, 2025.

Earnings Date	Feb 6, 2025
Ex-Dividend Date	Jan 3, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-3.52%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.02B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.27, with an EV/FCF ratio of 12.71.

EV / Earnings	-24.16
EV / Sales	3.43
EV / EBITDA	8.27
EV / EBIT	18.07
EV / FCF	12.71

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 2.99.

Current Ratio	1.24
Quick Ratio	1.02
Debt / Equity	2.99
Debt / EBITDA	2.62
Debt / FCF	3.73
Interest Coverage	5.05

Financial Efficiency

Return on equity (ROE) is -31.33% and return on invested capital (ROIC) is 8.20%.

Return on Equity (ROE)	-31.33%
Return on Assets (ROA)	6.07%
Return on Invested Capital (ROIC)	8.20%
Return on Capital Employed (ROCE)	12.65%
Revenue Per Employee	1.04M
Profits Per Employee	-158,803
Employee Count	34,100
Asset Turnover	0.51
Inventory Turnover	3.97

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +46.99% in the last 52 weeks. The beta is 0.44, so Bristol-Myers Squibb Company's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	+46.99%
50-Day Moving Average	57.64
200-Day Moving Average	50.01
Relative Strength Index (RSI)	57.82
Average Volume (20 Days)	12,963

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.53

Income Statement

In the last 12 months, Bristol-Myers Squibb Company had revenue of GBP 35.39 billion and -5.42 billion in losses. Loss per share was -2.67.

Revenue	35.39B
Gross Profit	26.85B
Operating Income	6.71B
Pretax Income	-5.13B
Net Income	-5.42B
EBITDA	14.30B
EBIT	6.71B
Loss Per Share	-2.67

Full Income Statement

Balance Sheet

The company has 6.04 billion in cash and 38.38 billion in debt, giving a net cash position of -32.10 billion.

Cash & Cash Equivalents	6.04B
Total Debt	38.38B
Net Cash	-32.10B
Net Cash Per Share	n/a
Equity (Book Value)	12.83B
Book Value Per Share	6.31
Working Capital	4.06B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.19 billion and capital expenditures -895.32 million, giving a free cash flow of 10.30 billion.

Operating Cash Flow	11.19B
Capital Expenditures	-895.32M
Free Cash Flow	10.30B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.87%, with operating and profit margins of 18.95% and -15.30%.

Gross Margin	75.87%
Operating Margin	18.95%
Pretax Margin	-14.50%
Profit Margin	-15.30%
EBITDA Margin	40.40%
EBIT Margin	18.95%
FCF Margin	29.10%

Dividends & Yields

This stock pays an annual dividend of 1.90, which amounts to a dividend yield of 2.61%.

Dividend Per Share	1.90
Dividend Yield	2.61%
Dividend Growth (YoY)	2.76%
Years of Dividend Growth	3
Payout Ratio	n/a
Buyback Yield	3.52%
Shareholder Yield	6.14%
Earnings Yield	-5.63%
FCF Yield	10.71%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Bristol-Myers Squibb Company has an Altman Z-Score of 1.91. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.91
Piotroski F-Score	n/a